Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | FASN | P49327 | 1/20 | 0.41 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.41 |
| ▸ | CSNK2A2 | P19784 | 4/20 | 0.39 |
| ▸ | CSNK2B | P67870 | 4/20 | 0.39 |
| ▸ | CSNK2A1 | P68400 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29699646 | 1.00 | MEN1 (0.41) | MEN1KMT2ACYP3A4ALDH1A1HPGD | |
| SCHEMBL27896979 | 0.84 | MEN1 (0.48) | MEN1KMT2ACYP3A4ALDH1A1HPGD | |
| SCHEMBL1973909 | 0.81 | MEN1 (0.53) | MEN1KMT2ACYP3A4ALDH1A1HPGD | |
| SCHEMBL1976272 | 0.81 | MEN1 (0.53) | MEN1KMT2ACYP3A4ALDH1A1HPGD | |
| SCHEMBL18293522 | 0.80 | ESR1 (0.45) | MEN1KMT2ACYP3A4ALDH1A1HPGD | |
| SCHEMBL4846708 | 0.80 | MEN1 (0.48) | MEN1KMT2ACYP3A4ALDH1A1HPGD | |
| SCHEMBL13499635 | 0.77 | XDH (0.55) | MEN1KMT2ACYP3A4ALDH1A1HPGD | |
| SCHEMBL15210311 | 0.75 | CSNK2A2 (0.46) | MEN1KMT2ACYP3A4ALDH1A1HPGD | |
| SCHEMBL18223919 | 0.74 | FASN (0.70) | MEN1KMT2AALDH1A1KDM4EMAPT | |
| SCHEMBL29442899 | 0.74 | TNKS2 (0.49) | MEN1KMT2ACYP3A4ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116994653-A | Sepsis diagnosis model construction method, compound screening method and electronic equipment | 南方医科大学南方医院 | 2023-11-03 | — | — | CN | claimed |
| CN-116994653-A | Sepsis diagnosis model construction method, compound screening method and electronic equipment | 南方医科大学南方医院 | 2023-11-03 | — | — | CN | disclosed |
| US-11066378-B2 | Caffeic acid derivatives for anti-angiogenesis | TAIPEI MEDICAL UNIVERSITY (TW) | 2021-07-20 | — | — | US | disclosed |
| CN-104771601-B | A kind of combination agent for improving blood viscosity and hematoblastic aggregation | 张坤镛 | 2018-06-19 | — | — | CN | disclosed |
| US-20160355493-A1 | CAFFEIC ACID DERIVATIVES FOR ANTI-ANGIOGENESIS | CHINA MEDICAL UNIVERSITY (TW) | 2016-12-08 | — | — | US | disclosed |
| US-9131648-B2 | Genes encoding chavicol/eugenol synthase from the creosote bush Larrea tridentata | WASHINGTON STATE UNIVERSITY (US) | 2015-09-15 | — | — | US | disclosed |
| US-9131648-B2 | Genes encoding chavicol/eugenol synthase from the creosote bush Larrea tridentata | WASHINGTON STATE UNIVERSITY (US) | 2015-09-15 | — | — | US | disclosed |
| CN-104771601-A | Combination agent for improving blood viscosity and platelet aggregation | ZHANG KUNYONG | 2015-07-15 | — | — | CN | disclosed |
| US-20100031398-A1 | GENES ENCODING CHAVICOL/EUGENOL SYNTHASE FROM THE CREOSOTE BUSH LARREA TRIDENTATA | WASHINGTON STATE UNIVERSITY (US) | 2010-02-04 | — | — | US | disclosed |
| US-20100031398-A1 | GENES ENCODING CHAVICOL/EUGENOL SYNTHASE FROM THE CREOSOTE BUSH LARREA TRIDENTATA | WASHINGTON STATE UNIVERSITY (US) | 2010-02-04 | — | — | US | disclosed |
| US-20050181080-A1 | Chinese traditional medicines for psoriasis | HUANG HSU-SHAN (TW) | 2005-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160355493-A1 | CAFFEIC ACID DERIVATIVES FOR ANTI-ANGIOGENESIS | VEGFA, KDR, FLT1 | MEN1 4091/4885KMT2A 697/4885CYP3A4 3246/4885 |
| US-20100031398-A1 | GENES ENCODING CHAVICOL/EUGENOL SYNTHASE FROM THE CREOSOTE BUSH LARREA TRIDENTATA | CNOT1, CRAT, LRAT | MEN1 4874/4885KMT2A 1080/4885CYP3A4 305/4885 |
| US-11066378-B2 | Caffeic acid derivatives for anti-angiogenesis | VEGFA, KDR, FLT1 | MEN1 4091/4885KMT2A 697/4885CYP3A4 3246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.